Richard Doubleday, EVP Chief Commercial Officer at DEXCOM INC (DXCM), sold 2,209 shares at $368.20 ($815K) on 2021-01-22, disclosed to the SEC on 2021-01-25.
Seasonal sale ($815k) by EVP Chief Commercial Officer — this insider has traded DXCM in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $367.51 | 366 | $135K | 16.5% |
| 2 | $367.51 | 366 | $135K | 16.5% |
| 3 | $368.20 | 169 | $62K | 7.6% |
| 4 | $368.20 | 169 | $62K | 7.6% |
| 5 | $369.31 | 254 | $94K | 11.5% |
| 6 | $369.31 | 254 |
| $94K |
| 11.5% |
| 7 | $370.24 | 310 | $115K | 14.1% |
| 8 | $370.24 | 310 | $115K | 14.1% |
| 9 | $371.98 | 11 | $4K | 0.5% |
| Total | $368.82 avg | 2,209 | $815K | 100% |
| Filing → |
| DXCM | SELL | 2021-01-06 | $8.1M | — | Filing → |
| DXCM | SELL | 2020-12-28 | $661K | — | Filing → |
| DXCM | SELL | 2020-11-25 | $708K | — | Filing → |